The Treasury Department’s Office of Foreign Assets Control (OFAC) included numerous wallet addresses associated with two individuals from Russia in its list of specially...
SIMLANDI is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S.
SIMLANDI is the first biosimilar approval under the strategic...
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on...
LAS VEGAS–(BUSINESS WIRE)–$AGREE #AGREE—Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company (“Ault Alliance,” or the “Company”), today announced strategic plans for the...
